Subscribe to RSS
DOI: 10.1055/s-0041-111534
Sequential Bilateral Non-Arteritic Anterior Ischaemic Optic Neuropathy in Superficial Intracranial Siderosis
Fortschreitende bilaterale nicht arteriitische anteriore ischämische Optikusneuropathie bei Superfizieller Intrakranieller SiderosePublication History
Publication Date:
26 April 2016 (online)
Background
Superficial intracranial siderosis (SIS) is a rare and often unrecognized disorder of the central nervous system (CNS) characterized by progressive neuronal degeneration resulting from chronic subarachnoid bleeding. Hemoglobin accumulates in the subarachnoid space where it is metabolized to hemosiderin and deposited in the subpial layer of those parts of the CNS adjacent to the cerebrospinal fluid with predilection for inter alia the cerebellum and cranial nerves I, II and VIII. Hemosiderin deposits lead to neuronal damage, reactive gliosis, and demyelination. Often the hemorrhage is occult and no bleeding source can be detected. Classic symptoms are sensorineural deafness, cerebellar ataxia and pyramidal signs [1]. Ophthalmic symptoms such as nystagmus have also been reported. Visual dysfunction however is not a recognized feature of SIS. Indeed, patients in an advanced stage have been shown to have normal optic nerve function [2]. Polidori et al documented a case of optic nerve dysfunction in a patient with SIS and concomitant glaucoma [3]. In 2008 Koeppen et al postulated that visual failure solely due to SIS does not occur [4]. But Painter et al reported two cases of SIS with strong evidence of optic nerve dysfunction and one postmortem case of histological findings of iron deposition and associated demyelination in the optic nerve [5]. Magnetic resonance imaging (MRI) is the diagnostic method of choice showing features of hemosiderin accumulation on CNS surfaces [4].
-
References
- 1 Fearnley JM, Stevens JM, Rudge P. Superficial siderosis of the nervous system. Brain 1995; 118: 1051-1066
- 2 River Y, Honigman S, Gomori JM et al. Superficial hemosiderosis of the central nervous system. Mov Disord 1994; 9: 559-562
- 3 Polidori MC, Pelliccioli G, Catani M et al. Superficial siderosis of the central nervous system: a 70 year old man with ataxia, depression and visual deficits. Gerontology 2001; 47: 93-95
- 4 Koeppen AH, Michael SC, Li D et al. The pathology of superficial siderosis of the central nervous system. Acta Neuropathol 2008; 116: 371-382
- 5 Painter SL, Mathew L, Quaghebeur G et al. Optic neuropathy in superficial intracranial siderosis. J Neuroophthalmol 2010; 30: 311-314
- 6 Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond) 2015; 29: 65-79
- 7 Arnold AC, Hepler RS, Hamilton DR et al. Magnetic resonance imaging of the brain in nonarteritic ischemic optic neuropathy. J Neuroophthalmol 1995; 15: 158-160
- 8 Worrall BB, Moazami G, Odel JG et al. Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature. J Neuroophthalmol 1997; 17: 162-165
- 9 Hayreh SS. Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2008; 28: 77-78 author reply 78–79
- 10 Kupersmith MJ, Frohman L, Sanderson M et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 1997; 17: 250-253